|
Volumn 118, Issue 2, 2002, Pages 432-433
|
Sab - A promising new treatment to improve remission rates in AML in the elderly?
|
Author keywords
AML; Historical controls; Randomized trials; Remission rates
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTARABINE;
DAUNORUBICIN;
TIOGUANINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CONTROLLED STUDY;
DRUG EFFICACY;
HUMAN;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ACUTE DISEASE;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYTARABINE;
DAUNORUBICIN;
DISEASE-FREE SURVIVAL;
HUMANS;
LEUKEMIA, MYELOID;
REMISSION INDUCTION;
THIOGUANINE;
|
EID: 0036039465
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2002.03620.x Document Type: Article |
Times cited : (19)
|
References (6)
|